Maclean's commemorative issue: Diana - Do the royals want her forgotten? Can her Sons Save her Legacy? Plus: Exploring her life in pictures

    In death, Diana was beatified, and the Queen took a beating. Ten years
    on, the princess's saintliness has dulled while the monarchy enjoys
    renewed esteem. Also in the issue of Maclean's hitting newsstands today:
    Conservative snarl and pets on Prozak.

    TORONTO, June 7 /CNW/ - Do you remember where you were when Diana died?
Like 9/11 or Kennedy's assassination, the crash in the Paris underpass sent
shock waves round the world as the princess briefly stopped it to get off. In
Britain, half the population went mad, washed away on a tide of hysteria and
flooding Kensington Palace, the home of the princess, with a torrent of
flowers, cuddly toys and an estimated 50 tonnes of memorial tat.
    "Ten years ago," writes Maclean's contributor Rosalind Miles, "Diana in
death became a princess heroine, a secular martyr who had died for love."
Seeking only a man she could trust, so the myth ran, she had been hounded to
her grave by a pack of pitiless paparazzi. Diana was in love with Dodi, they
were going to be married, she was carrying his child. And now she was dead -
in headlines everywhere, one of the most widely reported events in newspaper
    Fast forward 10 years, and how things have changed. Year by year,
adjustments to our understanding of Diana have besmirched her saintliness,
while the Queen has seen the royal family climb back to long-lost levels of
esteem. Miles asks, "What happened to reverse such strong views?"

    Conservative Snarl

    The most pronounced trait so far of the Harper era, or what the Tories
hope will last long enough to get that label, is its more general non-stop,
top-down partisan snarl. It can be heard in the relentless negative
advertising, two sets of ads each in English and French launched by the Tories
this year aimed at defining Stéphane Dion as a leader who doesn't know how to
lead. "It extends to the confrontational mood in House committees," writes
Maclean's Ottawa bureau chief John Geddes, "and to the relentless
keep-your-game-face-on, permanent campaign mode maintained by Harper's
retinue, even when there is no sign of an election on the horizon." Is it just
partisan nastiness, or is there a method to their meanness?

    Pets on Prozak?

    It's the newest vogue in pet care: pharmaceuticals. "In the past three
months," writes Maclean's correspondent Nancy Macdonald, "the U.S. Food and
Drug Administration has approved three doggie drugs for American use." One,
Cerenia, works like Gravol, treating canine motion sickness. Another, a 
$2-aday appetite suppressant called Slentrol, is aimed at America's 17 million
overweight dogs. It comes from Pfizer Inc., which has dedicated 600
researchers and an annual $270 million to develop new drugs for pets. All
told, the pet pharma sector has developed more than two dozen new drugs,
including sychoactives like Anipryl for doggie dementia, and Clomicalm, a
version of the old-school antidepressant clomipramine, used to treat
separation anxiety in pets.

    Also, be sure to check out the Interview:

    Elizabeth May: The Green party leader on her deal with Dion, why she'd be
a better MP than Peter MacKay, and how she'll make a splash next election.

    About Maclean's:

    Maclean's is Canada's only national weekly current affairs magazine.
Maclean's enlightens, engages and entertains 2.9 million readers with strong
investigative reporting and exclusive stories from leading journalists in the
fields of international affairs, social issues, national politics, business
and culture. Visit

For further information:

For further information: Jacqueline Segal, (416) 764-4125,

Organization Profile


More on this organization

News - Media

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890